Doctor Daniel Oder
Wuerzburg (Germany)
Follow
Contributor content
Presentation
Role of sudden cardiac death as end-stage complication in Fabry disease cardiomyopathy: Impact of primary and secondary prophylactic ICD therapy on long-term outcome
Presentation
Role of serum biomarkers for monitoring disease progression in the cardio-specific alpha-galactosidase A genotype N215S
Presentation
Hereditary cardiomyopathies: The N215S genotype in the alpha galactosidase A gene as an underestimated differential diagnosis of isolated left-ventricular hypertrophy
Presentation
